| scholarly article | Q13442814 |
| P2093 | author name string | James L McManaman | |
| David J Orlicky | |||
| Andrew E Libby | |||
| Elise Bales | |||
| P2860 | cites work | The Obesity Epidemic | Q22252322 |
| A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response | Q24305069 | ||
| Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta | Q24598068 | ||
| Unsaturated fatty acids inhibit proteasomal degradation of Insig-1 at a postubiquitination step | Q24655209 | ||
| Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells | Q28116233 | ||
| Lipid droplets in lipogenesis and lipolysis | Q28265077 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6 | Q37163041 | ||
| Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo | Q37267126 | ||
| From the metabolic syndrome to NAFLD or vice versa? | Q37703968 | ||
| Roles of PPARs in NAFLD: potential therapeutic targets | Q37953148 | ||
| Stearoyl CoA desaturase 1: role in cellular inflammation and stress | Q37972614 | ||
| Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials | Q37978785 | ||
| ATP-citrate lyase: a mini-review. | Q38009130 | ||
| Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | Q38090905 | ||
| Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements | Q38295025 | ||
| Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. | Q38297724 | ||
| Lipid-dependent regulation of the unfolded protein response | Q38301758 | ||
| Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. | Q38302026 | ||
| Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression | Q38347368 | ||
| Decrease in membrane phospholipid unsaturation induces unfolded protein response | Q41868507 | ||
| Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction. | Q42216030 | ||
| Srebp2: A master regulator of sterol and fatty acid synthesis | Q42591209 | ||
| Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms | Q45300618 | ||
| Membrane lipid saturation activates IRE1α without inducing clustering | Q46157031 | ||
| A 13C isotope labeling strategy reveals the influence of insulin signaling on lipogenesis in C. elegans | Q47069457 | ||
| PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice. | Q51798503 | ||
| Mammary glands of adipophilin-null mice produce an amino-terminally truncated form of adipophilin that mediates milk lipid droplet formation and secretion. | Q53523154 | ||
| Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. | Q54390800 | ||
| Elovl6 promotes nonalcoholic steatohepatitis | Q58207361 | ||
| Effect of dietary cholesterol and/or omega 3 fatty acids on lipid composition and delta 5-desaturase activity of rat liver microsomes | Q69827876 | ||
| Effects of a high-fat diet on energy metabolism and ROS production in rat liver | Q82615002 | ||
| Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis | Q85307305 | ||
| Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways | Q28576771 | ||
| AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice | Q28591122 | ||
| Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes | Q28646399 | ||
| SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | Q29547646 | ||
| Molecular mediators of hepatic steatosis and liver injury | Q29616709 | ||
| Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells | Q31582971 | ||
| Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet | Q33584753 | ||
| Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol | Q33731981 | ||
| Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis | Q33734679 | ||
| Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells | Q33778696 | ||
| Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice | Q33825040 | ||
| Regulation of basal cellular physiology by the homeostatic unfolded protein response | Q33886820 | ||
| Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes | Q33918445 | ||
| Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte | Q33923114 | ||
| Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice | Q33993281 | ||
| Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein | Q34302451 | ||
| Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease | Q34357996 | ||
| Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil | Q34636643 | ||
| Elovl6: a new player in fatty acid metabolism and insulin sensitivity | Q34658185 | ||
| Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism | Q35006878 | ||
| Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha | Q35209149 | ||
| Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection | Q35867161 | ||
| XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. | Q36322684 | ||
| SREBPs: sterol-regulated transcription factors | Q36416721 | ||
| Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice | Q36462135 | ||
| Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression | Q36473631 | ||
| Pathophysiology of lipid droplet proteins in liver diseases | Q36553968 | ||
| Perilipin2 plays a positive role in adipocytes during lipolysis by escaping proteasomal degradation | Q36579588 | ||
| Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains | Q36712468 | ||
| Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. | Q36725247 | ||
| Docosahexaenoic acid (DHA) and hepatic gene transcription | Q36725271 | ||
| Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease | Q36754811 | ||
| Inhibition of ADRP prevents diet-induced insulin resistance | Q36877282 | ||
| Hepatic triglyceride synthesis and nonalcoholic fatty liver disease | Q37156321 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 24231-24246 | |
| P577 | publication date | 2016-09-27 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome | |
| P478 | volume | 291 |
| Q64084143 | Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model |
| Q89790021 | Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice |
| Q90390497 | Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2 |
| Q93078660 | Diethylstilbestrol inhibits human and rat 11β-hydroxysteroid dehydrogenase 2 |
| Q90638448 | Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis |
| Q57807657 | Molecular pathways of nonalcoholic fatty liver disease development and progression |
| Q57027990 | Muscle-specific Perilipin2 down-regulation affects lipid metabolism and induces myofiber hypertrophy |
| Q50152028 | New Method for Quantitation of Lipid Droplet Volume From Light Microscopic Images With an Application to Determination of PAT Protein Density on the Droplet Surface. |
| Q91386361 | New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery |
| Q88984043 | Perilipin-2 deletion promotes carbohydrate-mediated browning of white adipose tissue at ambient temperature |
| Q40064092 | Perilipin-2 modulates dietary fat-induced microbial global gene expression profiles in the mouse intestine |
| Q90402623 | Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions |
| Q92544525 | Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device |
| Q90410771 | The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice |
| Q47813075 | The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis |
| Q58604344 | miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease |
Search more.